![]()
|
|
||||||||
J. Biol. Chem., Vol. 265, Issue 1, 241-247, Jan, 1990
PJ Hogg and CM Jackson
The binding of human alpha-thrombin (IIa) to fibrin polymer (FnIIp) was
studied in the presence and absence of a high affinity 20,300 Mr heparin
(H) at pH 7.4, I 0.15, and 23 degrees C. In the absence of heparin,
thrombin interacts with a high affinity class of binding sites on fibrin
polymer with a dissociation constant of 301 +/- 36 nM in a manner which is
independent of the enzyme active site. Studies of thrombin binding as a
function of heparin and fibrin polymer concentrations imply that a ternary
thrombin-fibrin polymer-heparin complex (IIa.FnIIp.H) is formed. Assembly
of the ternary complex occurs randomly through the interactions of all
three possible intermediate binary complexes; IIa.H, IIa.FnIIp, and
FnIIp.H. Using an independently determined value of 280 +/- 35 nM for the
FnIIp.H dissociation constant, global fits of the binding data yield a
dissociation constant of 15 +/- 6 nM for the IIa.H interaction and 47 +/- 9
nM for the IIa.H intermediate binary complex interaction with FnIIp. These
studies indicate that heparin enhances the binding of thrombin to fibrin
polymer 6.4-fold with an overall dissociation constant for ternary complex
formation of 705 nM2. The effect of heparin molecular weight on ternary
complex formation has also been investigated. Heparins of molecular weights
11,200-20,300 behave similarly with respect to their influence on ternary
complex formation, whereas heparins of lower molecular weight are less
effective in promoting thrombin binding to fibrin polymer. This effect of
heparin is also independent of whether it has high or low affinity for
antithrombin III. The demonstration of the formation of a ternary
IIa.FnIIp.H complex complements kinetic evidence indicating the formation
of an analogous ternary complex with fibrin II monomer (Hogg, P. J., and
Jackson, C. M. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 3619-3623). The
possible implications of these findings for the in vivo distribution and
actions of thrombin and the clinical efficacy of heparin are also
discussed.
Heparin promotes the binding of thrombin to fibrin polymer. Quantitative characterization of a thrombin-fibrin polymer-heparin ternary complex
American Red Cross Blood Services, Southeastern Michigan Region, Detroit, Michigan 48232.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
I. M. Verhamme, S. T. Olson, D. M. Tollefsen, and P. E. Bock Binding of Exosite Ligands to Human Thrombin. RE-EVALUATION OF ALLOSTERIC LINKAGE BETWEEN THROMBIN EXOSITES I AND II J. Biol. Chem., February 22, 2002; 277(9): 6788 - 6798. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Field, C. N. Chesterman, Y.-P. Dai, and P. J. Hogg Lupus Antibody Bivalency Is Required to Enhance Prothrombin Binding to Phospholipid J. Immunol., May 15, 2001; 166(10): 6118 - 6125. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Becker, J. C. Fredenburgh, A. R. Stafford, and J. I. Weitz Exosites 1 and 2 Are Essential for Protection of Fibrin-bound Thrombin from Heparin-catalyzed Inhibition by Antithrombin and Heparin Cofactor II J. Biol. Chem., March 5, 1999; 274(10): 6226 - 6233. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Hogg, C. M. Jackson, J. K. Labanowski, and P. E. Bock Binding of Fibrin Monomer and Heparin to Thrombin in a Ternary Complex Alters the Environment of the Thrombin Catalytic Site, Reduces Affinity for Hirudin, and Inhibits Cleavage of Fibrinogen J. Biol. Chem., October 18, 1996; 271(42): 26088 - 26095. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Meh, K. R. Siebenlist, and M. W. Mosesson Identification and Characterization of the Thrombin Binding Sites on Fibrin J. Biol. Chem., September 20, 1996; 271(38): 23121 - 23125. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. T. Esmon and P. Lollar Involvement of Thrombin Anion-binding Exosites 1and 2in the Activation of Factor V and Factor VIII J. Biol. Chem., June 7, 1996; 271(23): 13882 - 13887. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Mruk, P. Zoldhelyi, M. W.I. Webster, M. Heras, D. E. Grill, D. R. Holmes Jr, V. Fuster, and J. H. Chesebro Does Antithrombotic Therapy Influence Residual Thrombus After Thrombolysis of Platelet-Rich Thrombus? : Effects of Recombinant Hirudin, Heparin, or Aspirin Circulation, February 15, 1995; 93(4): 792 - 799. [Abstract] [Full Text] |
||||
![]() |
P. C. Y. Liaw, D. L. Becker, A. R. Stafford, J. C. Fredenburgh, and J. I. Weitz Molecular Basis for the Susceptibility of Fibrin-bound Thrombin to Inactivation by Heparin Cofactor II in the Presence of Dermatan Sulfate but Not Heparin J. Biol. Chem., June 8, 2001; 276(24): 20959 - 20965. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |